{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T22:29:53Z","timestamp":1772317793341,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_170702"],"award-info":[{"award-number":["PP00P3_170702"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Emerging drug resistance and high-attrition rates in early and late stage drug development necessitate accelerated development of antimalarial compounds. However, systematic and meaningful translation of drug efficacy and host-parasite dynamics between preclinical testing stages is missing. We developed an ensemble of mathematical within-host parasite growth and antimalarial action models, fitted to extensive data from four antimalarials with different modes of action, to assess host-parasite interactions in two preclinical drug testing systems of murine parasite <jats:italic>P. berghei<\/jats:italic> in mice, and human parasite <jats:italic>P. falciparum<\/jats:italic> in immune-deficient mice. We find properties of the host-parasite system, namely resource availability, parasite maturation and virulence, drive <jats:italic>P. berghei<\/jats:italic> dynamics and drug efficacy, whereas experimental constraints primarily influence <jats:italic>P. falciparum<\/jats:italic> infection and drug efficacy. Furthermore, uninvestigated parasite behavior such as dormancy influences parasite recrudescence following non-curative treatment and requires further investigation. Taken together, host-parasite interactions should be considered for meaningful translation of pharmacodynamic properties between murine systems and for predicting human efficacious treatment.<\/jats:p>","DOI":"10.1038\/s41598-020-61304-8","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T11:03:11Z","timestamp":1583838191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ensemble modeling highlights importance of understanding parasite-host behavior in preclinical antimalarial drug development"],"prefix":"10.1038","volume":"10","author":[{"given":"Lydia","family":"Burgert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Rottmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Wittlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Gobeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Dingemanse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg J.","family":"M\u00f6hrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4972-593X","authenticated-orcid":false,"given":"Melissa A.","family":"Penny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"61304_CR1","unstructured":"World Health Organization. (2018) World malaria report 2018. World Helath Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/275867. License: CC BY-NC-SA 3.0 IGO"},{"key":"61304_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0384-6","volume":"13","author":"M Tanner","year":"2015","unstructured":"Tanner, M. et al. Malaria eradication and elimination: views on how to translate a vision into reality. BMC Med. 13, 167, https:\/\/doi.org\/10.1186\/s12916-015-0384-6 (2015).","journal-title":"BMC Med."},{"key":"61304_CR3","unstructured":"World Health Organization. (2017). Artemisinin and artemisinin-based combination therapy resistance: status report. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/255213. License: CC BY-NC-SA 3.0 IGO"},{"key":"61304_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"TN Wells","year":"2015","unstructured":"Wells, T. N., Hooft van Huijsduijnen, R. & Van Voorhis, W. C. Malaria medicines: a glass half full? Nat. Rev. Drug. Discov. 14, 424\u2013442, https:\/\/doi.org\/10.1038\/nrd4573 (2015).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"61304_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1675-x","volume":"16","author":"JN Burrows","year":"2017","unstructured":"Burrows, J. N. et al. New developments in anti-malarial target candidate and product profiles. Malar. J. 16, 26, https:\/\/doi.org\/10.1186\/s12936-016-1675-x (2017).","journal-title":"Malar. J."},{"key":"61304_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrmicro3138","volume":"11","author":"EL Flannery","year":"2013","unstructured":"Flannery, E. L., Chatterjee, A. K. & Winzeler, E. A. Antimalarial drug discovery - approaches and progress towards new medicines. Nat. Rev. Microbiol. 11, 849\u2013862, https:\/\/doi.org\/10.1038\/nrmicro3138 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"61304_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/s0031182013000991","volume":"141","author":"MB Jim\u00e9nez-D\u00edaz","year":"2014","unstructured":"Jim\u00e9nez-D\u00edaz, M. B., Viera, S., Fern\u00e1ndez-Alvaro, E. & Angulo-Barturen, I. Animal models of efficacy to accelerate drug discovery in malaria. Parasitology 141, 93\u2013103, https:\/\/doi.org\/10.1017\/s0031182013000991 (2014).","journal-title":"Parasitology"},{"key":"61304_CR8","doi-asserted-by":"publisher","first-page":"e66967","DOI":"10.1371\/journal.pone.0066967","volume":"8","author":"MB Jim\u00e9nez-D\u00edaz","year":"2013","unstructured":"Jim\u00e9nez-D\u00edaz, M. B. et al. A new in vivo screening paradigm to accelerate antimalarial drug discovery. PLoS One 8, e66967, https:\/\/doi.org\/10.1371\/journal.pone.0066967 (2013).","journal-title":"PLoS One"},{"key":"61304_CR9","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1128\/AAC.02883-15","volume":"60","author":"JS McCarthy","year":"2016","unstructured":"McCarthy, J. S. et al. Linking murine and human Plasmodium falciparum challenge models in a translational path for antimalarial drug development. Antimicrob. Agents Chemother. 60, 3669\u20133675, https:\/\/doi.org\/10.1128\/AAC.02883-15 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61304_CR10","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1128\/aac.00519-09","volume":"53","author":"MB Jimenez-Diaz","year":"2009","unstructured":"Jimenez-Diaz, M. B. et al. Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. Antimicrob. Agents Chemother. 53, 4533\u20134536, https:\/\/doi.org\/10.1128\/aac.00519-09 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61304_CR11","doi-asserted-by":"publisher","first-page":"e2252","DOI":"10.1371\/journal.pone.0002252","volume":"3","author":"I Angulo-Barturen","year":"2008","unstructured":"Angulo-Barturen, I. et al. A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PLoS One 3, e2252, https:\/\/doi.org\/10.1371\/journal.pone.0002252 (2008).","journal-title":"PLoS One"},{"key":"61304_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-23","volume":"10","author":"J Langhorne","year":"2011","unstructured":"Langhorne, J. et al. The relevance of non-human primate and rodent malaria models for humans. Malar. J. 10, 23, https:\/\/doi.org\/10.1186\/1475-2875-10-23 (2011).","journal-title":"Malar. J."},{"key":"61304_CR13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acsinfecdis.6b00144","volume":"2","author":"MA Phillips","year":"2016","unstructured":"Phillips, M. A. et al. A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with improved drug-like properties for treatment and prevention of malaria. ACS Infect. Dis 2, 945\u2013957, https:\/\/doi.org\/10.1021\/acsinfecdis.6b00144 (2016).","journal-title":"ACS Infect. Dis"},{"key":"61304_CR14","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1208\/s12248-014-9647-y","volume":"16","author":"JA Simpson","year":"2014","unstructured":"Simpson, J. A., Zaloumis, S., DeLivera, A. M., Price, R. N. & McCaw, J. M. Making the most of clinical data: reviewing the role of pharmacokineticpharmacodynamic models of anti-malarial drugs. AAPS J. 16, 962\u2013974, https:\/\/doi.org\/10.1208\/s12248-014-9647-y (2014).","journal-title":"AAPS J."},{"key":"61304_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pt.2016.09.004","volume":"33","author":"HC Slater","year":"2017","unstructured":"Slater, H. C., Okell, L. C. & Ghani, A. C. Mathematical Modelling to Guide Drug Development for Malaria Elimination. Trends Parasitol. 33, 175\u2013184, https:\/\/doi.org\/10.1016\/j.pt.2016.09.004 (2017).","journal-title":"Trends Parasitol."},{"key":"61304_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1017\/S0031182000066245","volume":"113","author":"C Hetzel","year":"1996","unstructured":"Hetzel, C. & Anderson, R. M. The within-host cellular dynamics of bloodstage malaria: theoretical and experimental studies. Parasitology 113, 25\u201338 (1996).","journal-title":"Parasitology"},{"key":"61304_CR17","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/jac\/dku120","volume":"69","author":"K Patel","year":"2014","unstructured":"Patel, K., Batty, K. T., Moore, B. R., Gibbons, P. L. & Kirkpatrick, C. M. Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model. J. Antimicrobial Chemother. 69, 2155\u20132163, https:\/\/doi.org\/10.1093\/jac\/dku120 (2014).","journal-title":"J. Antimicrobial Chemother."},{"key":"61304_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/jtbi.1997.0438","volume":"194","author":"DJ Austin","year":"1998","unstructured":"Austin, D. J., White, N. J. & Anderson, R. M. The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics. J. Theor. Biol. 194, 313\u2013339, https:\/\/doi.org\/10.1006\/jtbi.1997.0438 (1998).","journal-title":"J. Theor. Biol."},{"key":"61304_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1128\/aac.01463-12","volume":"57","author":"K Patel","year":"2013","unstructured":"Patel, K. et al. Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria. Antimicrob. Agents Chemother. 57, 508\u2013516, https:\/\/doi.org\/10.1128\/aac.01463-12 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61304_CR20","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1128\/AAC.00252-10","volume":"54","author":"SF Hietala","year":"2010","unstructured":"Hietala, S. F. et al. Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania. Antimicrob. Agents Chemother. 54, 4780\u20134788, https:\/\/doi.org\/10.1128\/AAC.00252-10 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61304_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1017\/S0031182001007533","volume":"122","author":"L Molineaux","year":"2001","unstructured":"Molineaux, L. et al. Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology 122, 379\u2013391 (2001).","journal-title":"Parasitology"},{"key":"61304_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00228-002-0485-y","volume":"58","author":"US Svensson","year":"2002","unstructured":"Svensson, U. S., Alin, H., Karlsson, M. O., Bergqvist, Y. & Ashton, M. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria. Eur. J. Clin. Pharmacol. 58, 339\u2013351, https:\/\/doi.org\/10.1007\/s00228-002-0485-y (2002).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"61304_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/imr.12697","volume":"285","author":"DS Khoury","year":"2018","unstructured":"Khoury, D. S. et al. Within-host modeling of blood-stage malaria. Immunological Rev 285, 168\u2013193, https:\/\/doi.org\/10.1111\/imr.12697 (2018).","journal-title":"Immunological Rev"},{"key":"61304_CR24","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cmdc.201600298","volume":"11","author":"C Boss","year":"2016","unstructured":"Boss, C. et al. Discovery and characterization of ACT-451840: an antimalarial drug with a novel mechanism of action. ChemMedChem 11, 1995\u20132014, https:\/\/doi.org\/10.1002\/cmdc.201600298 (2016).","journal-title":"ChemMedChem"},{"key":"61304_CR25","doi-asserted-by":"publisher","first-page":"e1002138","DOI":"10.1371\/journal.pmed.1002138","volume":"13","author":"A Le Bihan","year":"2016","unstructured":"Le Bihan, A. et al. Characterization of novel antimalarial compound ACT-451840: preclinical assessment of activity and dose-efficacy modeling. PLoS Med. 13, e1002138, https:\/\/doi.org\/10.1371\/journal.pmed.1002138 (2016).","journal-title":"PLoS Med."},{"key":"61304_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/bcp.12962","volume":"82","author":"A Krause","year":"2016","unstructured":"Krause, A. et al. Pharmacokinetic\/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects. Br. J. Clin. Pharmacol. 82, 412\u2013421, https:\/\/doi.org\/10.1111\/bcp.12962 (2016).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"61304_CR27","doi-asserted-by":"publisher","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"MA Phillips","year":"2017","unstructured":"Phillips, M. A. et al. Malaria. Nat. Rev. Dis. Prim 3, 17050, https:\/\/doi.org\/10.1038\/nrdp.2017.50 (2017).","journal-title":"Nat. Rev. Dis. Prim"},{"key":"61304_CR28","doi-asserted-by":"publisher","first-page":"eaad9735","DOI":"10.1126\/scitranslmed.aad9735","volume":"9","author":"T Paquet","year":"2017","unstructured":"Paquet, T. et al. Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci. Transl. Med. 9, eaad9735, https:\/\/doi.org\/10.1126\/scitranslmed.aad9735 (2017).","journal-title":"Sci. Transl. Med."},{"key":"61304_CR29","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1021\/acs.jmedchem.6b01586","volume":"60","author":"Y Dong","year":"2017","unstructured":"Dong, Y. et al. Structure-activity relationship of the antimalarial ozonide artefenomel (OZ439). J. Med. Chem. 60, 2654\u20132668, https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01586 (2017).","journal-title":"J. Med. Chem."},{"key":"61304_CR30","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1073\/pnas.1015762108","volume":"108","author":"SA Charman","year":"2011","unstructured":"Charman, S. A. et al. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc. Natl Acad. Sci. U S Am. 108, 4400\u20134405, https:\/\/doi.org\/10.1073\/pnas.1015762108 (2011).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61304_CR31","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ijpara.2006.07.009","volume":"36","author":"D Cromer","year":"2006","unstructured":"Cromer, D., Evans, K. J., Schofield, L. & Davenport, M. P. Preferential invasion of reticulocytes during late-stage Plasmodium berghei infection accounts for reduced circulating reticulocyte levels. Int. J. Parasitology 36, 1389\u20131397, https:\/\/doi.org\/10.1016\/j.ijpara.2006.07.009 (2006).","journal-title":"Int. J. Parasitology"},{"key":"61304_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1182\/blood-2006-09-018069","volume":"110","author":"AA Lamikanra","year":"2007","unstructured":"Lamikanra, A. A. et al. Malarial anemia: of mice and men. Blood 110, 18\u201328, https:\/\/doi.org\/10.1182\/blood-2006-09-018069 (2007).","journal-title":"Blood"},{"key":"61304_CR33","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1073\/pnas.1618939114","volume":"114","author":"DS Khoury","year":"2017","unstructured":"Khoury, D. S. et al. Host-mediated impairment of parasite maturation during blood-stage Plasmodium infection. Proc. Natl Acad. Sci. U S Am. 114, 7701\u20137706, https:\/\/doi.org\/10.1073\/pnas.1618939114 (2017).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61304_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s004360050091","volume":"82","author":"E Deharo","year":"1996","unstructured":"Deharo, E., Coquelin, F., Chabaud, A. G. & Landau, I. The erythrocytic schizogony of two synchronized strains of Plasmodium berghei, NK65 and ANKA, in normocytes and reticulocytes. Parasitol. Res. 82, 178\u2013182 (1996).","journal-title":"Parasitol. Res."},{"key":"61304_CR35","doi-asserted-by":"publisher","unstructured":"White, N. J. The parasite clearance curve. Malar. J. 10, https:\/\/doi.org\/10.1186\/1475-2875-10-278 (2011).","DOI":"10.1186\/1475-2875-10-278"},{"key":"61304_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0014-4894(90)90063-I","volume":"71","author":"JL Villeval","year":"1990","unstructured":"Villeval, J. L., Gearing, A. & Metcalf, D. Changes in hemopoietic and regulator levels in mice during fatal or nonfatal malarial infections. II. Nonerythroid populations. Exp. Parasitol 71, 375\u2013385 (1990).","journal-title":"Exp. Parasitol"},{"key":"61304_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/IAI.00982-08","volume":"77","author":"JK Nunes","year":"2009","unstructured":"Nunes, J. K., Starnbach, M. N. & Wirth, D. F. Secreted antibody is required for immunity to Plasmodium berghei. J. Infect. Immun 77, 414\u2013418, https:\/\/doi.org\/10.1128\/IAI.00982-08 (2009).","journal-title":"J. Infect. Immun"},{"key":"61304_CR38","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1128\/AAC.46.4.958-965.2002","volume":"46","author":"S Nakazawa","year":"2002","unstructured":"Nakazawa, S., Maoka, T., Uemura, H., Ito, Y. & Kanbara, H. Malaria parasites giving rise to recrudescence in vitro. Antimicrob. Agents Chemother. 46, 958\u2013965, https:\/\/doi.org\/10.1128\/AAC.46.4.958-965.2002 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61304_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-339","volume":"10","author":"JA Flegg","year":"2011","unstructured":"Flegg, J. A., Guerin, P. J., White, N. J. & Stepniewska, K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar. J. 10, 339, https:\/\/doi.org\/10.1186\/1475-2875-10-339 (2011).","journal-title":"Malar. J."},{"key":"61304_CR40","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","volume":"41","author":"NJ White","year":"1997","unstructured":"White, N. J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41, 1413\u20131422 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61304_CR41","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1128\/aac.04942-14","volume":"59","author":"L Marquart","year":"2015","unstructured":"Marquart, L., Baker, M., O\u2019Rourke, P. & McCarthy, J. S. Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR. Antimicrob. Agents Chemother. 59, 4249\u20134259, https:\/\/doi.org\/10.1128\/aac.04942-14 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Pt 3","key":"61304_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1017\/S0031182099006368","volume":"121","author":"MB Hoshen","year":"2000","unstructured":"Hoshen, M. B., Heinrich, R., Stein, W. D. & Ginsburg, H. Mathematical modelling of the within-host dynamics of Plasmodium falciparum. Parasitology 121(Pt 3), 227\u2013235 (2000).","journal-title":"Parasitology"},{"key":"61304_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trstmh.2004.01.016","volume":"99","author":"MM Thapar","year":"2005","unstructured":"Thapar, M. M., Gil, J. P. & Bjorkman, A. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil. Trans. R. Soc. Trop. Med. Hyg. 99, 62\u201370, https:\/\/doi.org\/10.1016\/j.trstmh.2004.01.016 (2005).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"61304_CR44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.ijpara.2017.05.009","volume":"47","author":"DS Khoury","year":"2017","unstructured":"Khoury, D. S. et al. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo. Int. J. Parasitol. 47, 913\u2013922, https:\/\/doi.org\/10.1016\/j.ijpara.2017.05.009 (2017).","journal-title":"Int. J. Parasitol."},{"key":"61304_CR45","doi-asserted-by":"publisher","first-page":"e12408","DOI":"10.1371\/journal.pone.0012408","volume":"5","author":"MI Veiga","year":"2010","unstructured":"Veiga, M. I. et al. Antimalarial Exposure Delays Plasmodium falciparum Intra-Erythrocytic Cycle and Drives Drug Transporter Genes Expression. PLoS One 5, e12408, https:\/\/doi.org\/10.1371\/journal.pone.0012408 (2010).","journal-title":"PLoS One"},{"key":"61304_CR46","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1098\/rspb.2012.1792","volume":"279","author":"P Schneider","year":"2012","unstructured":"Schneider, P. et al. Virulence, drug sensitivity and transmission success in the rodent malaria, Plasmodium chabaudi. Proc. Biol. Sci. 279, 4677\u20134685, https:\/\/doi.org\/10.1098\/rspb.2012.1792 (2012).","journal-title":"Proc. Biol. Sci."},{"key":"61304_CR47","doi-asserted-by":"publisher","first-page":"6096","DOI":"10.1128\/aac.00072-15","volume":"59","author":"MM Plucinski","year":"2015","unstructured":"Plucinski, M. M., Morton, L., Bushman, M., Dimbu, P. R. & Udhayakumar, V. Robust algorithm for systematic classification of malaria late treatment failures as recrudescence or reinfection using microsatellite genotyping. Antimicrob. Agents Chemother. 59, 6096\u20136100, https:\/\/doi.org\/10.1128\/aac.00072-15 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61304_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4269\/ajtmh.2005.73.256","volume":"73","author":"M Slater","year":"2005","unstructured":"Slater, M. et al. Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. Am. J. Trop. Med. Hyg. 73, 256\u2013262 (2005).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"61304_CR49","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S1471-4922(02)02373-5","volume":"18","author":"NJ White","year":"2002","unstructured":"White, N. J. The assessment of antimalarial drug efficacy. Trends Parasitol. 18, 458\u2013464 (2002).","journal-title":"Trends Parasitol."},{"key":"61304_CR50","unstructured":"R Core Team (2018). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, URL https:\/\/www.R-project.org\/."},{"key":"61304_CR51","unstructured":"Schmidt, H., Kuemmel, A. & Kaschek, D. IQRtools: Modeling and simulation across systems pharmacology and pharmacometrics. R package version 0.9.999, https:\/\/github.com\/IntiQuan\/IQRtools (2018)."},{"key":"61304_CR52","unstructured":"Monolix version 2016R1. Antony, France: Lixoft SAS, 2016. http:\/\/lixoft.com\/products\/monolix\/."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61304-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:02:41Z","timestamp":1670313761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61304-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61304"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61304-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.G. and J.J.M. are employees of Medicines for Malaria Venture. A.K. and J.D. are employees of Idorsia. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4410"}}